Mining Companies Must Obtain Free, Prior, Informed Consent, Partner with Indigenous Peoples to Ensure Responsible, Ethical Land Use, Speakers Tell Permanent Forum
United Nations: Meetings Coverage and Press Releases, 23 April 2025
Excerpt
Mining companies must obtain free, prior and informed consent from Indigenous Peoples when pursuing projects on their ancestral lands, speakers emphasized at the 2025 session of the Permanent Forum on Indigenous Issues — a high-level advisory body to the Economic and Social Council. Participants also discussed how partnerships can mobilize adequate development finance for Indigenous communities… The Permanent Forum has before it a related study (document E/C.19/2025/6), titled “The rights of Indigenous Peoples in the context of critical minerals to ensure a just transition”…
Category: Symposia/Conferences
Symposia/Conferences/Webinars
SYMPOSIA/CONFERENCES/WEBINARS
We will selectively include information on major symposia and conferences which address issues, evidence, analysis or debates involving consent/assent. This listing will include [1] meetings already concluded but which are posting presentations/recordings, etc.; [2] future meetings which have posted registration/logistics information, and [3] meetings which have announced calls for abstracts/panels, etc.
Patient-Centered Informed Consent in Clinical Study of FDA-Regulated Medical Products
FDA Patient Engagement Advisory Committee Meeting
Webinar: October 30, 2024
Video recording: [7:13] https://www.youtube.com/live/Th3fkIpi3vc
AGENDA:
On October 30, 2024, the Committee discussed and made recommendations on “Patient-Centered Informed Consent in Clinical Study of FDA-Regulated Medical Products.”
The individuals who volunteer to participate in clinical research play an integral role in advancing scientific knowledge and supporting the development of potentially life-saving therapies for patients in need. Informed consent is a key element in clinical studies and can be one of a patient’s first interactions with the clinical community. Too often, however, informed consent forms are lengthy and difficult for potential research participants to understand. FDA has worked to improve informed consent over the years, including several recent activities such as developing a draft guidance in identifying key information in informed consent.
The Committee will provide recommendations on the informed consent process and the areas of focus of the informed consent. The Committee will also provide recommendations on factors to consider when communicating informed consent to clinical study participants to increase the likelihood of participants understanding the key elements of research. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting, the background material will be made publicly available on FDA’s website at the time of the advisory committee meeting, and the background material will be posted on FDA’s website after the meeting.
Background material and the link to the online teleconference and/or video conference meeting are available at https://www.fda.gov/AdvisoryCommittee….
Briefing Documents providing further information:
Symposia/Conferences
We will selectively include information on major symposia and conferences which address issues, evidence, analysis or debates involving consent/assent. This listing will include [1] meetings already concluded but which are posting presentations/recordings, etc.; [2] future meeting which have posted registration/logistics information, and [3] meetings which have announced calls for abstracts/panels, etc.
8th World Conference on Research Integrity (Hybrid)
2-5 June 2024
Megaron Athens International Conference Centre (MAICC)
Athens, Greece
The biannual WCRIs cater to all disciplinary fields, all professional ranks, and all career stages, and involve all stakeholders in research integrity, including universities, research institutes, research funders, publishers, and governments. Each WCRI emphasises a specific theme, but all cater for the whole range of research integrity issues and responsible research practices. The 8th WCRI will put thematic emphasis on: Catalysing the translation of research into trustworthy policy and innovation.
Call for Abstracts now open, deadline October 17, 2023.
Symposia/Conferences
We will selectively include information on major symposia and conferences which address issues, evidence, analysis or debates involving consent/assent. This listing will include [1] meetings already concluded but which are posting presentations/recordings, etc.; [2] future meeting which have posted registration/logistics information, and [3] meetings which have announced calls for abstracts/panels, etc.
17th World Congress of Bioethics
3-6 June 2024
Doha, Qatar
The WCB 2024 theme is “Religion, Culture, and Global Bioethics”. This theme aims to engage bioethics researchers from a broad range of fields and disciplines and to take full advantage of hosting the WCB in the Arab-Muslim world and the Middle East
Call for Abstracts now open, deadline September 30, 2023.
Editor’s Note: We are certainly aware of the continuing, active debate in the bioethics community and beyond about the site selection for this meeting. The Foundation is reviewing its options regarding participation, submitting abstracts, etc.
8th World Conference on Research Integrity (Hybrid)
2-5 June 2024
Megaron Athens International Conference Centre (MAICC)
Athens, Greece
The biannual WCRIs cater to all disciplinary fields, all professional ranks, and all career stages, and involve all stakeholders in research integrity, including universities, research institutes, research funders, publishers, and governments. Each WCRI emphasises a specific theme, but all cater for the whole range of research integrity issues and responsible research practices. The 8th WCRI will put thematic emphasis on: Catalysing the translation of research into trustworthy policy and innovation.
Call for Abstracts now open, deadline October 17, 2023.
Symposia/Conferences
SYMPOSIA/CONFERENCES
We will selectively include information on symposia and conferences which included papers/panels/ workshops which treat issues, evidence, analysis or debates involving consent/assent. Generally, we will identify specific sessions in such meetings with a link to a recorded version [i.e. You Tube].
UNESCO – International Conference on the Ethics of Neurotechnology
13 July 2023, UNESCO Paris
UNESCO organized an International Conference on the Ethics of Neurotechnology on the theme “Towards an Ethical Framework in the Protection and Promotion of Human Rights and Fundamental Freedoms” at UNESCO Headquarters in Paris, on 13 July 2023.
As one of the most promising technologies of our time, neurotechnology is providing new treatments and improving preventative and therapeutic options for millions of individuals suffering from neurological and mental illness. Neurotechnology is also transforming other aspects of our lives, from student learning and cognition to virtual and augmented reality systems and entertainment. While we celebrate these unprecedented opportunities, we must be vigilant against new challenges arising from the rapid and unregulated development and deployment of this innovative technology, including among others the risks to mental integrity, human dignity, personal identity, autonomy, fairness and equity, and mental privacy.
Engaging all relevant stakeholders, including policymakers, lawmakers, scientists, ethicists, practitioners, and private sector companies, is crucial to gather various views and prepare the ground for shaping the ethical governance of neurotechnology.
Event recording: https://webcast.unesco.org/events/2023-07-neurotech/
Supporting documentation:
Ethical issues of neurotechnology: report, adopted in December 2021
Corporate author : International Bioethics Committee [200]
ISBN : 978-92-3-100551-0 Collation : 93 pages Language : English Year of publication : 2022
Workshop on Ethics of Sharing Individual Level Human Brain Data Collected in Biomedical Research
NIH BRAIN Initiative
July 17 and 18, 2023
Data sharing accelerates scientific progress and maximizes the societal value of research, providing an ethical imperative to share data. The ethical considerations tied to the sharing of human brain data may be different than sharing other kinds of biomedical data. Indeed, sharing human research data may involve potential risks to participants or communities. NIH is committed to promoting responsible data sharing (NOT-OD-21-013). In order to put appropriate safeguards in place to manage potential risks of data sharing, a better understanding of what the risks are of sharing different types of human brain data is critical.
The NIH BRAIN Initiative is at the forefront of data sharing in neuroscience (see NOT-MH-19-010). As such, it also has an opportunity to carefully consider the ethical challenges involved, especially with the input of the BRAIN Neuroethics Working Group (NEWG), a group of experts in neuroethics and neuroscience.
The workshop aims to explore meaningful ways to categorize human brain data by potential risks of data sharing. Furthermore, any resulting differences in how to treat the data will be considered.
Center for Informed Consent Integrity 